Capital Group Investment Management Pte. Ltd. Regeneron Pharmaceuticals, Inc. Transaction History

Capital Group Investment Management Pte. Ltd.

$475 Million
Q3 2024

A detailed history of Capital Group Investment Management Pte. Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Capital Group Investment Management Pte. Ltd. holds 7,468 shares of REGN stock, worth $5.56 Million. This represents 1.65% of its overall portfolio holdings.

Number of Shares

7,468

Previous 7,437 0.42%

Holding current value

$5.56 Million

Previous $7.82 Million 0.44%

% of portfolio

1.65%

Previous 1.76%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $31,746 - $37,254	31 Added 0.42%	7,468 $7.85 Million
Q2 2024 Aug 13, 2024	SELL	$883.2 - $1071.19 $620,006 - $751,975	-702 Reduced 8.63%	7,437 $7.82 Million
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $4.92 Million - $5.42 Million	-5,453 Reduced 40.12%	8,139 $7.83 Million
Q4 2023 Feb 13, 2024	SELL	$775.18 - $881.7 $9.4 Million - $10.7 Million	-12,127 Reduced 47.15%	13,592 $11.9 Million
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $2.51 Million - $3.07 Million	-3,630 Reduced 12.37%	25,719 $21.2 Million
Q2 2023 Aug 11, 2023	BUY	$700.03 - $830.35 $1.01 Million - $1.2 Million	1,444 Added 5.17%	29,349 $21.1 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $9.13 Million - $11.1 Million	-13,416 Reduced 32.47%	27,905 $22.9 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $29.2 Million - $31.7 Million	41,321 New	41,321 $0

Others Institutions Holding REGN

# of Institutions

1,531

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Group Investment Management Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Capital Group Investment Management Pte. Ltd. with notifications on news.

Account

Capital Group Investment Management Pte. Ltd. Regeneron Pharmaceuticals, Inc. Transaction History